NCT04550377View on ClinicalTrials.gov

Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Post Traumatic Stress DisorderTraumatic Brain Injury
Interventions
DRUG

Cannabidiol

The drug product to be used in this study is an oral formulation of CBD

DRUG

Placebo

non-active medication

Trial Locations (1)

10016

RECRUITING

New York University School of Medicine, New York

All Listed Sponsors
collaborator

Brockman Foundation

UNKNOWN

lead

NYU Langone Health

OTHER